{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:58:06Z","timestamp":1774857486394,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Oncology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/s1470-2045(06)70867-1","type":"journal-article","created":{"date-parts":[[2006,9,8]],"date-time":"2006-09-08T15:52:19Z","timestamp":1157730739000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":825,"title":["Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Amar","family":"Gajjar","sequence":"first","affiliation":[]},{"given":"Murali","family":"Chintagumpala","sequence":"additional","affiliation":[]},{"given":"David","family":"Ashley","sequence":"additional","affiliation":[]},{"given":"Stewart","family":"Kellie","sequence":"additional","affiliation":[]},{"given":"Larry E","family":"Kun","sequence":"additional","affiliation":[]},{"given":"Thomas E","family":"Merchant","sequence":"additional","affiliation":[]},{"given":"Shaio","family":"Woo","sequence":"additional","affiliation":[]},{"given":"Greg","family":"Wheeler","sequence":"additional","affiliation":[]},{"given":"Valerie","family":"Ahern","sequence":"additional","affiliation":[]},{"given":"Matthew J","family":"Krasin","sequence":"additional","affiliation":[]},{"given":"Maryam","family":"Fouladi","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Broniscer","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Krance","sequence":"additional","affiliation":[]},{"given":"Gregory A","family":"Hale","sequence":"additional","affiliation":[]},{"given":"Clinton F","family":"Stewart","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Dauser","sequence":"additional","affiliation":[]},{"given":"Robert A","family":"Sanford","sequence":"additional","affiliation":[]},{"given":"Christine","family":"Fuller","sequence":"additional","affiliation":[]},{"given":"Ching","family":"Lau","sequence":"additional","affiliation":[]},{"given":"James M","family":"Boyett","sequence":"additional","affiliation":[]},{"given":"Dana","family":"Wallace","sequence":"additional","affiliation":[]},{"given":"Richard J","family":"Gilbertson","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1470-2045(06)70867-1_bib1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/1097-0142(19880515)61:10<1992::AID-CNCR2820611011>3.0.CO;2-J","article-title":"Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984: the influence of radiation dose and pattern of failure","volume":"61","author":"Hughes","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S1470-2045(06)70867-1_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11940-006-0022-x","article-title":"Current therapy for medulloblastoma","volume":"8","author":"Gottardo","year":"2006","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","article-title":"Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study","volume":"17","author":"Zeltzer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ejca.2004.12.017","article-title":"Outcome of patients with metastatic (M2\u20133) medulloblastoma treated with SIOP\/UKCCSG PNET-3 chemotherapy","volume":"41","author":"Taylor","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/S1470-2045(06)70867-1_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","article-title":"Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT 91","volume":"46","author":"Kortmann","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(06)70867-1_bib6","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1200\/JCO.1996.14.9.2495","article-title":"Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors: the Children's Cancer Study Group","volume":"14","author":"Finaly","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib7","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.1997.15.5.1814","article-title":"High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors","volume":"15","author":"Graham","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.1998.16.1.222","article-title":"High-dose carboplatin, thiotepa and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma: Children's Cancer Group","volume":"16","author":"Dunkel","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib9","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.1998.16.7.2486","article-title":"Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent brain tumors","volume":"16","author":"Gururangan","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1200\/JCO.1996.14.2.382","article-title":"High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent progressive malignant brain tumors in children. A pilot Pediatric Oncology Group study","volume":"14","author":"Mahoney","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00043426-199505000-00006","article-title":"A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumors","volume":"17","author":"Abrahemsen","year":"1995","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mpo.2950240406","article-title":"Dose escalation trial of cyclophosphamide with saragamostim in the treatment of central nervous system (CNS) neoplasms","volume":"24","author":"Lachance","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","article-title":"Dose a critical factor in cancer chemotherapy","volume":"69","author":"Frei","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/S1470-2045(06)70867-1_bib14","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1200\/JCO.2001.19.10.2696","article-title":"Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative trial","volume":"19","author":"Strother","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1148\/93.6.1351","article-title":"An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma","volume":"93","author":"Chang","year":"1969","journal-title":"Radiology"},{"key":"10.1016\/S1470-2045(06)70867-1_bib16","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","article-title":"Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations","volume":"24","author":"Thompson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib17","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1200\/JCO.2004.10.103","article-title":"Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor","volume":"22","author":"Stewart","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib18","series-title":"World Health Organization classification of tumours: pathology and genetics of tumours of the nervous system","author":"Kleihues","year":"2000"},{"key":"10.1016\/S1470-2045(06)70867-1_bib20","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1200\/JCO.1995.13.9.2247","article-title":"Preirradiation chemotherapy with Carboplatin and Etoposide in newly diagnosed embryonal pediatric CNS tumors","volume":"13","author":"Heideman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: analyses and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1016\/S1470-2045(06)70867-1_bib22","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","article-title":"Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy. A Children's Cancer Group Study","volume":"17","author":"Packer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib23","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III prospective randomized study of craniospinal radiation therapy followed by one of two adjuvant chemotherapy regimens for newly-diagnosed average risk medulloblastoma","volume":"24","author":"Packer","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ijrobp.2005.11.002","article-title":"Radiotherapy in pediatric medulloblastoma: quality assessment of pediatric oncology group trial 9031","volume":"64","author":"Miralbell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S1470-2045(06)70867-1_bib25","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1200\/JCO.2005.00.760","article-title":"Standard-risk medulloblastoma treated with adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study","volume":"23","author":"Oyharcabal-Bourden","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2003.05.116","article-title":"Results of a randomized study of pre-irradiation chemotherapy vs radiotherapy regimen alone for non-metastatic (M0\u2013M1) medulloblastoma. The SIOP\/UKCCSG PNET-3 study","volume":"21","author":"Taylor","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1702806","article-title":"Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with Neuroblastoma and medulloblastoma","volume":"27","author":"Vassal","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S1470-2045(06)70867-1_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00146088","article-title":"Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?","volume":"27","author":"Dupuis-Girod","year":"1996","journal-title":"J Neuroonocol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jnen\/62.6.627","article-title":"Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastoma","volume":"62","author":"McManamy","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(04)01424-X","article-title":"Medulloblastoma: signalling a change in treatment","volume":"5","author":"Gilbertson","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib32","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1200\/JCO.2005.01.5479","article-title":"\u03b2 catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumor Committee","volume":"23","author":"Ellison","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1470-2045(04)01507-4","article-title":"Late neurocognitive sequelae in survivors of brain tumours in childhood","volume":"5","author":"Mulhern","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib34","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1200\/JCO.2004.03.058","article-title":"White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor","volume":"22","author":"Fouladi","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S1470-2045(06)70867-1_bib27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3171\/jns.1994.81.5.0690","article-title":"Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy","volume":"81","author":"Packer","year":"1994","journal-title":"J Neurosurg"}],"updated-by":[{"DOI":"10.1016\/s1470-2045(06)70881-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000}}],"container-title":["The Lancet Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204506708671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470204506708671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:54:19Z","timestamp":1761458059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204506708671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1470204506708671"],"URL":"https:\/\/doi.org\/10.1016\/s1470-2045(06)70867-1","relation":{},"ISSN":["1470-2045"],"issn-type":[{"value":"1470-2045","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(06)70867-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1470-2045(06)70872-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}